Monday Morning Vaccine Breakthrough: Terrific News for the West, but in LMICs Terms and Conditions Apply

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-11-25

Type Web Page Author Rachel Silverman URL https://www.cgdev.org/blog/monday-morning-vaccine-breakthrough-terrific-news-west-lmics-terms-and-conditions-apply Date 09/11/2020 Website Type Blog Language en Abstract This morning, America (and much of the world) woke up to a snippet of terrific news: Pfizer and BioNTech announced their SARS-CoV2 vaccine candidate showed 90 percent efficacy. But for policymakers in low- and middle-income countries, today’s news offers limited cause for celebration—and the Pfizer/BioNTech results may even lengthen the timeline for eventual LMIC access. Website Title Center For Global Development Short Title Monday Morning Vaccine Breakthrough